ARCHIVES

European regulators plan more rigorous rules for accelerated approval in cancer.

This article is from The Cancer Letter archive.

Vol. 31 No. 41 | November 11, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Division To Promote Funds To Promote Collaboration.

February 18, 2000

Named VP, Health sciences At UNM

February 11, 1994

STAR Begins: Critics of Trial Call For Including A Placebo Arm

June 4, 1999

FCRC Preproposal Conference Draws 36 Institutions

August 14, 1981

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

FDA, Clinical Investigators Head Or Showdown Over Demand To See Individual Patient Records

April 18, 1980